Published online May 6, 2024. doi: 10.12998/wjcc.v12.i13.2237
Peer-review started: November 26, 2023
First decision: February 5, 2024
Revised: February 17, 2024
Accepted: April 3, 2024
Article in press: May 6, 2024
Published online: May 6, 2024
Processing time: 151 Days and 1.2 Hours
Breast conservation surgery (BCS) with adjuvant radiotherapy has become a gold standard in the treatment of early-stage breast cancer, significantly reducing the risk of tumor recurrence. However, this treatment is associated with adverse effects, including the rare but aggressive radiation-induced angiosarcoma (RIAS). Despite its rarity and nonspecific initial presentation, RIAS presents a challenging diagnosis, emphasizing the importance of imaging techniques for early detection and accurate diagnosis.
We present a case of a 48-year-old post-menopausal woman who developed skin ecchymosis on the right breast seven years after receiving BCS and adjuvant radiotherapy for breast cancer. Initial mammography and ultrasound were inconclusive, showing post-treatment changes but failing to identify the under
Breast MRI is crucial for detecting RIAS, especially when mammography and ultrasound are inconclusive.
Core Tip: Radiation-induced angiosarcoma (RIAS) of the breast is extremely rare and aggressive complication of the radiotherapy. The diagnosis is difficult clinically, radiologically and even pathologically. Mammography and ultrasound findings of RIAS are nonspecific and may be occult on the initial conventional breast imaging. Breast magnetic resonance imaging can provide better morphologic characterization and extent of disease, which is critical in surgical planning and preventing delays in diagnosis.
